Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NCAM1 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
mRNA | MYLK2 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
mRNA | ZNF519 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
mRNA | MAST1 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
mRNA | NRXN2 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
mRNA | KSR2 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
mRNA | VANGL2 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-07 |
mRNA | SMAD9 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-07 |
mRNA | CELF5 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
mRNA | CTD-2583A14.9 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |